WBCPI 100.32 0.0% BHP 45.37 0.688% CBA 134.61 0.313% RIO 126.04 0.0635% CSL 288.61 0.554% NAB 37.0 0.0541% WBC 30.71 -1.2858% ANZ 30.08 -0.0996% NEM 78.24 0.0384% MQG 226.55 0.1724% WES 69.03 0.0725% GMG 37.8 1.5583% FMG 19.98 -0.7944% SQ2 94.0 -1.3848% RMD 34.76 -0.4582% WDS 26.06 0.5789% WTC 134.6 -0.3553% TLS 3.88 -0.5128% TCL 13.19 0.7639% WOW 33.01 0.1213%
Last update at 2024-10-03T06:11:00Z
Cann Group First Half 2023 Earnings: AU$0.053 loss per share (vs AU$0.028 loss in 1H 2022)
Sun 26 Feb 23, 12:09 AMThe past three years for Cann Group (ASX:CAN) investors has not been profitable
Tue 03 May 22, 02:30 AMShareholders in Cann Group (ASX:CAN) are in the red if they invested three years ago
Sat 20 Nov 21, 10:44 PMCannabis Sector Weekly Roundup
Tue 07 Sep 21, 03:58 PMAurora Continues To Sell Assets, Places Focus On 'Core Markets'
Wed 14 Oct 20, 02:44 PMBreakdown | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 |
Income before tax | -33.79000M | -26.46800M | -25.10300M | -16.93739M | -10.92632M |
Minority interest | - | - | - | - | - |
Net income | -33.79000M | -26.46800M | -25.10300M | -16.93739M | -11.12523M |
Selling general administrative | 33.19M | 25.13M | 21.45M | 13.85M | 12.02M |
Selling and marketing expenses | - | - | - | - | - |
Gross profit | 13.78M | 6.41M | 4.25M | 0.00652M | 1.88M |
Reconciled depreciation | 11.96M | 4.80M | 2.63M | 2.16M | 1.45M |
Ebit | -29.96100M | -24.64000M | -20.95200M | -16.06836M | -10.72741M |
Ebitda | -18.00100M | -19.84300M | -18.32100M | -13.90835M | -9.25209M |
Depreciation and amortization | 11.96M | 4.80M | 2.63M | 2.16M | 1.48M |
Non operating income net other | - | - | - | - | - |
Operating income | -29.72600M | -24.24700M | -19.27000M | -16.33100M | -10.72741M |
Other operating expenses | -51.26600M | -35.87800M | -29.42400M | -16.64800M | 15.01M |
Interest expense | 3.16M | 1.83M | 4.15M | 0.87M | 0.20M |
Tax provision | 0.00000M | 0.00000M | 0.00000M | 0.00000M | 0.00000M |
Interest income | 4.43M | 2.22M | 0.04M | 0.61M | 1.45M |
Net interest income | -3.15800M | -1.82800M | -4.11000M | -0.86903M | 1.45M |
Extraordinary items | - | - | - | - | - |
Non recurring | - | - | - | - | - |
Other items | - | - | - | - | - |
Income tax expense | 9.78M | 6.26M | 6.70M | 1.82M | 0.20M |
Total revenue | 13.78M | 6.41M | 4.29M | 0.65M | 2.35M |
Total operating expenses | 50.36M | 35.48M | 27.79M | 17.29M | 14.54M |
Cost of revenue | - | - | 0.05M | 0.64M | 0.47M |
Total other income expense net | 5.95M | 4.43M | 2.55M | 0.95M | -0.19891M |
Discontinued operations | - | - | - | - | - |
Net income from continuing ops | -33.79000M | -26.46800M | -25.10300M | -16.93739M | -10.92632M |
Net income applicable to common shares | -33.79000M | -26.46800M | -25.10300M | -16.93739M | -10.92632M |
Preferred stock and other adjustments | - | - | - | - | - |
Breakdown | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 |
Total assets | 92.77M | 129.47M | 139.66M | 101.79M | 76.40M |
Intangible assets | - | 0.21M | 0.79M | 1.39M | 0.83M |
Earning assets | - | - | - | - | - |
Other current assets | 0.35M | 2.60M | 1.64M | 1.90M | 0.61M |
Total liab | 78.93M | 70.20M | 54.76M | 9.92M | 15.33M |
Total stockholder equity | 13.84M | 59.26M | 84.90M | 91.87M | 61.07M |
Deferred long term liab | - | - | - | - | - |
Other current liab | 2.65M | 0.43M | 0.16M | 0.14M | 0.96M |
Common stock | 182.90M | 177.37M | 169.43M | 149.67M | 97.14M |
Capital stock | - | 177.37M | 169.43M | 149.67M | 97.14M |
Retained earnings | -169.47200M | -118.23000M | -84.44000M | -61.16400M | -38.20538M |
Other liab | - | 0.14M | 0.10M | 0.25M | - |
Good will | - | - | 0.67M | 0.66M | 0.66M |
Other assets | - | 0.51M | 0.09M | 0.09M | 0.09M |
Cash | 1.64M | 0.77M | 1.91M | 3.10M | 1.55M |
Cash and equivalents | - | 0.77M | 1.91M | 3.10M | 1.55M |
Total current liabilities | 78.25M | 24.39M | 11.30M | 9.65M | 6.49M |
Current deferred revenue | 0.18M | 0.82M | 0.81M | 0.77M | -0.96300M |
Net debt | 70.91M | 60.20M | 45.25M | -2.42500M | 7.77M |
Short term debt | 72.05M | 15.29M | 3.80M | 0.41M | 0.49M |
Short long term debt | - | 15.29M | 3.50M | - | - |
Short long term debt total | 72.55M | 60.97M | 47.16M | 0.68M | 9.32M |
Other stockholder equity | - | -59.13800M | -84.98500M | -88.50900M | -58.93300M |
Property plant equipment | - | 107.40M | 118.20M | 76.43M | 61.95M |
Total current assets | 16.26M | 21.20M | 19.17M | 22.09M | 12.53M |
Long term investments | - | 0.14M | 0.74M | 1.22M | 1.01M |
Net tangible assets | - | 59.05M | 83.44M | 89.83M | 60.25M |
Short term investments | - | - | - | -0.08500M | -0.08484M |
Net receivables | 4.08M | 5.64M | 4.16M | 4.20M | 0.09M |
Long term debt | - | 45.67M | 43.36M | 0.00000M | 8.19M |
Inventory | 10.19M | 12.20M | 11.46M | 12.89M | 10.04M |
Accounts payable | 3.38M | 7.85M | 6.52M | 8.33M | 6.00M |
Total permanent equity | - | - | - | - | - |
Noncontrolling interest in consolidated entity | - | - | - | - | - |
Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
Accumulated other comprehensive income | 0.41M | 0.12M | -0.08200M | 3.36M | 2.14M |
Additional paid in capital | - | - | - | - | - |
Common stock total equity | - | - | - | - | 97.14M |
Preferred stock total equity | - | - | - | - | - |
Retained earnings total equity | - | - | - | - | - |
Treasury stock | - | - | - | - | - |
Accumulated amortization | - | - | - | - | - |
Non currrent assets other | 0.04M | -107.75000M | 0.09M | -79.61500M | 0.09M |
Deferred long term asset charges | - | - | - | - | - |
Non current assets total | 76.51M | 108.26M | 120.50M | 79.70M | 63.87M |
Capital lease obligations | - | - | 0.30M | 0.68M | 1.13M |
Long term debt total | - | 45.67M | 43.36M | 0.27M | 8.84M |
Breakdown | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 |
Investments | -0.02800M | -45.16400M | -0.81400M | -34.36241M | 28.88M |
Change to liabilities | 1.87M | -3.97100M | 3.24M | 1.19M | 3.75M |
Total cashflows from investing activities | -0.02800M | -45.16400M | -17.08400M | -34.36241M | 3.50M |
Net borrowings | 13.80M | 46.48M | -0.44700M | 7.59M | 0.74M |
Total cash from financing activities | 21.71M | 64.41M | 39.47M | 7.15M | 0.74M |
Change to operating activities | -0.74000M | 0.26M | -1.05400M | -0.11961M | -0.58450M |
Net income | -33.79000M | -26.46800M | -25.10300M | -16.93700M | -11.12523M |
Change in cash | -1.14900M | -1.19100M | 1.55M | -44.83420M | -3.17870M |
Begin period cash flow | 1.91M | 3.10M | 1.55M | 46.39M | 49.57M |
End period cash flow | 0.77M | 1.91M | 3.10M | 1.55M | 46.39M |
Total cash from operating activities | -22.83500M | -20.43300M | -20.83000M | -17.61900M | -7.42255M |
Issuance of capital stock | 7.92M | 17.92M | 40.20M | 8.00M | 0.74M |
Depreciation | 11.60M | 4.46M | 2.45M | 2.16M | 1.48M |
Other cashflows from investing activities | 3.07M | 0.00000M | -0.81400M | 0.00000M | 28.88M |
Dividends paid | - | - | - | - | - |
Change to inventory | -0.46300M | 1.44M | -2.85200M | -6.56400M | -1.47804M |
Change to account receivables | -2.10000M | 0.06M | -4.10400M | 1.02M | -1.11544M |
Sale purchase of stock | 7.92M | 17.92M | -0.28600M | -0.44256M | -0.44256M |
Other cashflows from financing activities | 17.30M | 46.48M | -0.44700M | -0.41066M | 0.44M |
Change to netincome | 0.42M | 3.46M | 6.42M | 1.63M | 1.37M |
Capital expenditures | 3.10M | 45.16M | 16.27M | 34.36M | 25.33M |
Change receivables | - | - | - | - | - |
Cash flows other operating | - | - | - | - | - |
Exchange rate changes | - | - | - | - | - |
Cash and cash equivalents changes | - | - | - | - | - |
Change in working capital | -2.56300M | 1.50M | -6.95600M | -5.54100M | 1.61M |
Stock based compensation | 0.19M | 0.74M | 0.58M | 0.70M | - |
Other non cash items | -0.64500M | 1.58M | 1.82M | -2.84100M | 9.48M |
Free cash flow | -25.93600M | -65.59700M | -37.10000M | -51.98141M | -25.32517M |
Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic
Company | Change (AUD) | Price (AUD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
---|---|---|---|---|---|---|---|---|
CAN Cann Group Ltd |
-0.004 5.71% | 0.07 | - | - | 1.69 | 2.22 | 6.62 | -4.2363 |
AFP AFT Pharmaceuticals Ltd |
- -% | 3.02 | 21.57 | 19.96 | 1.62 | 3.93 | 1.79 | 12.53 |
VLS Vita Life Sciences Ltd |
- -% | 2.22 | 13.06 | - | 1.58 | 2.57 | 1.24 | 7.15 |
PER Percheron Therapeutics Limited |
0.005 5.00% | 0.10 | - | - | 31.89 | 9.63 | 347.00 | -4.4641 |
LV1 Live Verdure Ltd |
- -% | 0.55 | - | - | 36.77 | 26.99 | 36.21 | -5.083 |
Cann Group Limited engages in the breeding, cultivation, production, manufacturing, supplying, and selling medicinal cannabis. It licenses to undertake research and to cultivate cannabis for human medicinal and research purposes. The company was founded in 2014 and is based in Port Melbourne, Australia.
262-276 Lorimer Street, Port Melbourne, VIC, Australia, 3207
Name | Title | Year Born |
---|---|---|
Mr. Peter Crock M.B.A., MBA | Chief Exec. Officer | NA |
Ms. Deborah Ambrosini B.Com., F.C.A. | CFO & Company Sec. | 1974 |
Mr. Shane Duncan | Chief Operating Officer | NA |
Mr. Geoff Aldred | Chief Projects & Information Officer | NA |
Mr. Clive Fanning | Head of Investor Relations | NA |
Mr. Steven Notaro | Head of Legal | NA |
Mr. Peter Koetsier | Chief Executive Officer | NA |
Mr. Steven Notaro BA, J.D. | Head of Legal and Regulatory Affairs & Company Secretary | NA |
Mr. Peter Koetsier | Chief Executive Officer | NA |
Mr. Steven Notaro BA, J.D. | Head of Legal and Regulatory Affairs & Company Secretary | NA |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.